Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S)

European Heart Journal

Volumn 17, Issue 7, 1996, Pages 1001-1007

  Jonsson, B ^a   Johannesson, M ^a   Kjekshus, J ^a   Olsson, A G ^a   Pedersen, T R ^a   Wedel, H ^a  

^a STOCKHOLM SCHOOL OF ECONOMICS   (Sweden)

Author keywords

Cholesterol lowering; Cost effectiveness; Simvastatin (4S)

Indexed keywords

CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; SIMVASTATIN;

ANGINA PECTORIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG MONITORING; HEALTH CARE COST; HEART INFARCTION; HOSPITALIZATION; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029901109     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.eurheartj.a014994     Document Type: Article

References (0)